CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 932 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 1,968 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,880 shares (grant or award)
- 4 Planned sale Chief Operating Officer sold 200 shares at $20.00 ($4,000)
- 4 Planned sale Chief Operating Officer sold 1,801 shares at an average $20.09 ($36,179)
- 4 Planned sale Chief Operating Officer sold 9,152 shares at an average $20.06 ($183,568)
- 4 Planned sale Chief Operating Officer sold 8,644 shares at an average $20.09 ($173,632)
- 4 Planned sale Chief Operating Officer sold 1,501 shares at $20.00 ($30,020)
- 4 Planned sale Chief Operating Officer sold 9,587 shares at $18.09 ($173,466)
- 4 Grant or award Director acquired 3,180,155 shares (grant or award)
Page 5 of 11 · 203 filings